CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
July 2023—Qiagen announced that its variant interpretation and reporting software, Qiagen Clinical Insight (QCI) Interpret, was chosen by the Danish National Genome Center to provide interpretation of oncology results generated from whole genome sequencing data. The initiative is part of a larger personalized medicine strategy that aims to provide WGS as the standard of care for relevant patient groups throughout Denmark.
QCI Interpret allows authorized staff from laboratories to interpret whole genome sequencing data while meeting Denmark’s data privacy and security requirements, the company says, for all data to be processed and stored within the country and accessed only from within the National Genome Center infrastructure.
Qiagen, +49 (2103) 29 12000